Plymouth Meeting-based Accolade saw its stock surge by nearly 10 percent after agreeing to acquire Texas-based 2nd.MD in a deal that is valued at up to $460 million, writes John George for the Philadelphia Business Journal.

Accolade is a technology and health care concierge company founded in 2007. It helps people navigate sometimes extremely complex medical delivery and workplace benefits.

According to the terms of the deal, Accolade will pay $230 million in cash and $130 million in common stock for the telemedicine company, as well as up to $100 million if certain revenue levels are met.

Accolade signed the agreement with 2nd.MD’s parent organization, Innovation Specialists. This medical opinion and medical decision support company is based in Houston.

It is expected the deal will close by the end of next month.

“We share a common vision to help every person live their healthiest life by dramatically improving quality and accessibility of care,” said Accolade CEO Rajeev Singh. “Both companies have built deep relationships with employers and health plans by helping employees navigate the increasingly complex and inconsistent health care system.”

Read more about Accolade at the Philadelphia Business Journal by clicking here.